Target intelligence / Profile preview

Pathogen adhesins and lectins

Molecular classification
Lectin, Adhesin, Surface protein, Glycan-binding protein
01

Overview

Pathogen adhesins and lectins are specialized surface molecules, primarily proteins, that mediate the attachment of microorganisms—including bacteria, viruses, and fungi—to host cell surfaces or the extracellular matrix [PubMed: 28257055]. Adhesins often constitute the tips of pili or fimbriae, while lectins are a specific class of adhesins that recognize and bind to complex carbohydrate structures (glycans) on host tissues [PubMed: 29233510]. This molecular recognition is the essential first step for colonization, tissue invasion, and the establishment of infection, as well as the formation of protective biofilms [PubMed: 31515370]. Because these interactions are highly specific, they represent attractive targets for anti-adhesion therapies, which aim to block the initial docking of the pathogen rather than exerting bactericidal or virucidal pressure. Therapeutic strategies include the use of glycomimetics, such as mannosides targeting the FimH adhesin in uropathogenic E. coli, and monoclonal antibodies that neutralize viral attachment proteins [PubMed: 31515370, PubMed: 28257055]. These approaches are particularly valuable in the context of rising antimicrobial resistance, as they may reduce the evolutionary pressure for pathogens to develop traditional resistance mechanisms.

Other names
Microbial adhesinsPathogen-associated lectinsAttachment proteinsColonization factorsAgglutininsViral attachment proteins
02

Mechanism of action

Competitive inhibition of pathogen-host binding to prevent colonization and infection.

03

Biological functions

Cell adhesionPathogen colonizationBiofilm formationHost-pathogen interactionViral entryTissue tropism
04

Disease associations

InfectionUrinary tract infectionRespiratory tract infectionGastrointestinal infectionSepsisBiofilm-associated infection
05

Safety considerations

Cross-reactivity with endogenous host lectinsRapid renal clearance of small-molecule glycomimeticsPotential for pathogen to switch to alternative adhesion pathwaysHigh dosage requirements for small-molecule glycomimetics
06

Interacting drugs

Sibofimloc (EB8018)

5 more in the full profile.

07

Biomarkers

Pathogen loadAdhesin expression levelsGlycan binding assaysBiofilm density

Beyond the preview

Go deeper on Pathogen adhesins and lectins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogen adhesins and lectins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call